Get the Stockscreener App
19.28
2.17%
0.41
Pre-market:
19.05
-0.23
-1.19%
Kenvue Inc stock is traded at $19.28, with a volume of 21.96M.
It is up +2.17% in the last 24 hours and up +9.11% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
See More
Previous Close:
$18.87
Open:
$18.97
24h Volume:
21.96M
Relative Volume:
0.96
Market Cap:
$37.03B
Revenue:
$15.29B
Net Income/Loss:
$1.62B
P/E Ratio:
22.86
EPS:
0.8433
Net Cash Flow:
$1.82B
1W Performance:
+7.05%
1M Performance:
+9.11%
6M Performance:
+11.45%
1Y Performance:
+29.14%
1-Day Range:
$0.00
$0.00
1-Week Range:
$18.38
$19.30
52-Week Range:
$14.02
$20.13
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
1 KENVUE WAY, SUMMIT
Compare KVUE vs PG, UL, CL, EL
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
19.28 | 37.03B | 15.29B | 1.62B | 1.82B | 0.8433 |
PG
Procter Gamble Co
|
159.32 | 370.05B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
65.22 | 140.45B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
94.54 | 75.36B | 20.80B | 2.22B | 3.77B | 2.5772 |
EL
Estee Lauder Cos Inc
|
106.12 | 38.45B | 14.85B | -248.00M | 1.29B | -0.6966 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Downgrade | Jefferies | Buy → Hold |
| Oct-29-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-26-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Apr-10-25 | Initiated | Redburn Atlantic | Neutral |
| Mar-24-25 | Initiated | Evercore ISI | In-line |
| Jan-06-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-12-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-24-24 | Initiated | Jefferies | Buy |
| Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-28-24 | Resumed | Citigroup | Neutral |
| Apr-11-24 | Initiated | Bernstein | Underperform |
| Apr-03-24 | Initiated | William Blair | Mkt Perform |
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Nike vs. Procter & Gamble: Which Consumer Stock Is a Better Buy in 2026? - The Motley Fool
Kimberly-Clark (KMB) Prices $4.9 Billion Senior Notes Offering t - GuruFocus
ETFs Are Net Sellers of Kenvue (KVUE) on Oct. 16 - Yahoo Finance
Kimberly-Clark prices $4.9B senior notes across five tranches to fund Kenvue acquisition - TradingView
Kimberly-Clark Prices $4.9 Billion Debt Offering Ahead of Kenvue Deal - marketscreener.com
Kimberly-Clark prices $4.9B senior notes to fund Kenvue acquisition - StreetInsider
Kimberly-Clark prices $4.9 billion debt offering for Kenvue deal By Investing.com - Investing.com India
Kimberly-Clark prices $4.9 billion debt offering for Kenvue deal - Investing.com
Kimberly-Clark Corporation (KMB) Prices $4.9B Notes for Kenvue Deal - TradingView
Kimberly-Clark Corporation Announces Pricing of $4.9 Billion Private Offering of Senior Notes - TradingView
Kenvue Loses Appeal Bid in Tylenol Autism Lawsuits - grafa.com
Kenvue loses bid for rehearing after Tylenol autism lawsuits revived - TradingView
Kimberly-Clark’s Kenvue Buy Clears EU Review After Agreeing To Divest European Tampon Brands - Medtech Insight
Kimberly-Clark Sells Bonds to Help Finance Kenvue Acquisition - marketscreener.com
Kimberly-Clark Offers Bonds to Help Fund Tylenol Maker Takeover - Bloomberg
Kenvue loses bid for rehearing after Tylenol autism lawsuits revived - Reuters
Kenvue Inc. stock rises Friday, outperforms market - MarketWatch
Kimberly-Clark Readies Bond Sale Ahead of Tylenol Maker Purchase - Bloomberg.com
A Look at Kenvue Inc (KVUE) After 3.7% Gain -- GF Value $20.01 v - GuruFocus
Kenvue Inc. stock rises Thursday, outperforms market - MarketWatch
Kenvue Inc. stock rises Thursday, outperforms market - MarketWatch
What to Expect From Kenvue's Next Quarterly Earnings Report - Yahoo Finance
What to Expect From Kenvue's Next Quarterly Earnings Report - Barchart.com
What to Expect From Kenvue's Next Quarterly Earnings Report - inkl
Kimberly-Clark posts preliminary results above estimates, China clears formamide claims - Reuters
EU approves Kimberly-Clark's Kenvue acquisition; Dilek to acquire Kotex, Camelia and Record - METissue
Kimberly-Clark’s $40 Billion Kenvue Takeover Clears EU Antitrust Review - PYMNTS.com
EU Approves Kimberly-Clark’s Acquisition Of Kenvue After Divestments Agreed - HBW Insight
EU approves Kimberly-Clark's $40 billion Kenvue acquisition - Reuters
Kimberly-Clark, Kenvue Win Conditional EU Approval for $40 Billion Tie-Up - WSJ
Kenvue Implements Third Supplemental Indenture, Easing Covenants for Kimberly-Clark's $7 Billion Note Exchange - TradingView
Kimberly-Clark receives consents for Kenvue note amendments By Investing.com - Investing.com Canada
Kimberly-Clark Receives Requisite Consents For Amendments To All Kenvue Notes - TradingView
Kimberly-Clark Announces Successful Consent Solicitations for Kenvue Notes and Amendment to Terms of Exchange Offers - PR Newswire
Kimberly-Clark Announces Successful Consent Solicitations for Kenvue Notes and Amendment to Terms of Exchange Offers - TradingView
Form 4 Kenvue Inc For: 11 October By Investing.com - Investing.com South Africa
2 Dividend Stocks Worth Holding Forever (Including 1 Dividend King) - The Motley Fool
PIMCO Global Core Asset Allocation Fund's Kenvue Inc(KVUE) Holding History - GuruFocus
Kenvue Inc. Research & Ratings | KVUE - Barron's
Kenvue Inc. stock rises Thursday, outperforms market - MarketWatch
Market Concentration Is Spooking Wall Street—I’m Buying Kenvue - Yahoo Finance
Kimberly-Clark’s (KMB) Kenvue (KVUE) Deal Has Jim Cramer Looking Years Ahead - Yahoo Finance
Form 4 Kenvue Inc For: 6 October By Investing.com - Investing.com Nigeria
24,732 shares go to Kenvue (KVUE) executive Caroline Tillett; 8,471 are withheld for taxes. - Stock Titan
A performance award vested at 100%; Kenvue (KVUE) executive received 36,597 shares. - Stock Titan
Kenvue Inc. stock rises Tuesday, outperforms market - MarketWatch
Kimberly-Clark announces leadership changes ahead of Kenvue acquisition - Tissue Online North America
NWL or KVUE: Which Is the Better Value Stock Right Now? - Zacks Investment Research
Kenvue Inc. (NYSE:KVUE) Stock Has Consensus Target Price of $19.00 - MarketBeat
An award vests into 66K shares for Kenvue (KVUE)’s Michael Wondrasch; 21,031 shares cover taxes. - Stock Titan
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Kenvue Inc Stock (KVUE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Howlett Heather | Officer |
Jun 10 '26 |
Proposed Sale |
18.11 |
3,700 |
66,988 |
0 |
| Howlett Heather | CFO & CAO |
Jun 10 '26 |
Sale |
18.11 |
3,700 |
66,988 |
29,288 |
| Orlando Matthew | General Counsel |
May 08 '26 |
Sale |
17.66 |
38,491 |
679,691 |
0 |
| Orlando Matthew | Officer |
May 08 '26 |
Proposed Sale |
17.66 |
38,492 |
679,691 |
0 |
| Curado Gomes de Lemos Leonardo | Group President LATAM |
May 01 '26 |
Option Exercise |
0.00 |
24,248 |
0 |
24,248 |
| Alvarado Luani | Chief People Officer |
Mar 10 '26 |
Option Exercise |
0.00 |
4,222 |
0 |
62,797 |
| Stevens Meredith | Chief Operations Officer |
Mar 10 '26 |
Option Exercise |
0.00 |
5,170 |
0 |
94,877 |
| Lawson Carlton | Group President EMEA & LA |
Mar 10 '26 |
Option Exercise |
0.00 |
6,158 |
0 |
111,415 |
| Lawson Carlton | Group President EMEA & LA |
Mar 05 '26 |
Option Exercise |
0.00 |
7,736 |
0 |
105,257 |
| Alvarado Luani | Chief People Officer |
Mar 05 '26 |
Option Exercise |
0.00 |
4,289 |
0 |
61,365 |
2.77%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):